Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and

Hongqi Lue1, Aphrodite Kapurniotu, Günter Fingerle-Rowson

  • 1Department of Biochemistry and Molecular Cell Biology, Institute of Biochemistry, University Hospital of the RWTH Aachen, Pauwelsstrasse 30, D-52074 Aachen, Germany.

Cellular Signalling
|August 27, 2005
PubMed

Insights

Macrophage migration inhibitory factor (MIF) rapidly activates the transient ERK pathway via Src-type kinases, a novel finding. This process is regulated by JAB1/CSN5, impacting cell proliferation and survival.

Area of Science:

  • Cellular Signaling
  • Molecular Biology
  • Immunology

Background:

  • Macrophage migration inhibitory factor (MIF) regulates critical cell functions but its signaling pathways are not fully understood.
  • While MIF's role in sustained ERK activation is known, its involvement in transient ERK activation and upstream pathways remains unclear.

Purpose of the Study:

  • To investigate the role of MIF in transient ERK pathway activation.
  • To identify the upstream signaling molecules and regulatory factors involved in MIF-induced transient ERK activation.

Main Methods:

  • Utilized MIF-deficient and Src-deficient cells.
  • Applied tyrosine kinase and Src kinase inhibitors (genistein, PP2).
  • Investigated the role of JAB1/CSN5 using overexpression and siRNA knockdown.

Main Results:

  • MIF rapidly and transiently activated the ERK pathway, involving Raf-1, MEK, ERK, and Elk-1 phosphorylation.
  • This activation was independent of autocrine MIF signaling and required upstream Src-type tyrosine kinase activity.
  • JAB1/CSN5 was essential for transient ERK activation but inhibited sustained ERK phosphorylation.

Conclusions:

  • MIF triggers a novel, rapid, and transient ERK pathway activation.
  • This pathway is initiated by Src-type kinase activation and modulated by JAB1/CSN5.
  • This unraveled pathway is crucial for regulating cell proliferation and survival.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...